ClinicalTrials.Veeva

Menu

The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass

I

Imam Khomeini Hospital

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Coronary Artery Disease
Chronic Kidney Disease stage3
Chronic Kidney Disease stage4

Treatments

Procedure: hemodialysis

Study type

Interventional

Funder types

Other

Identifiers

NCT01410617
THC-473

Details and patient eligibility

About

Coronary artery disease is a major cause of death in patients with renal dysfunction Among patients who undergo coronary artery bypass grafting ,renal dysfunction is known To be a major predictor of in-hospital and remote mortality As little is known about the impact of non-dialysis-dependent renal dysfunction on short and mid term Outcomes following coronary surgery we have decided to investigate the effect of prophylactic Hemodialysis on the mortality and morbidity of the patients with ckd (stage 3,4 ) and compare these Effect with the control group

Enrollment

120 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 80<age>18
  • ckd patients with stage 3,4
  • CABG for the first time

Exclusion criteria

  • age<18
  • previous CABG (coronary artery bypass grafting)
  • AKI(acute kidney injury)
  • dialysis patients

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

dialysis
Active Comparator group
Description:
the patients who undergo 3 sessions prophylactic hemodialysis
Treatment:
Procedure: hemodialysis
control group
No Intervention group
Description:
the patients who do not undergo hemodialysis

Trial contacts and locations

1

Loading...

Central trial contact

Mohamamd R khatami, MD; Roghieh Borji, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems